Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/ATelephone
61.2.9160.2305
Address
104 Derby Street Silverwater, New South Wales (NSW) 2128
Description
EZZ Life Science Holdings Ltd. is a genomic life science company, which engages in the business of formulating, producing, marketing, and selling branded health and wellbeing products to retailers and consumers domestically and internationally. It operates under the Brought in Lines and Company Owned segments. The company was founded by Qi Zhou Qin on September 22, 2015 is headquartered in Silverwater, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.45 - 3.0
Trade Value (12mth)
AU$27,972.00
1 week
8.27%
1 month
62.71%
YTD
368.29%
1 year
384.03%
All time high
3.00
EPS 3 yr Growth
234.60%
EBITDA Margin
15.20%
Operating Cashflow
$6m
Free Cash Flow Return
34.10%
ROIC
38.70%
Interest Coverage
408.30
Quick Ratio
5.60
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
27-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
28 August 24 |
Preliminary Final Report
×
Preliminary Final Report |
28 August 24 |
FY24 Full Year Results Summary
×
FY24 Full Year Results Summary |
28 August 24 |
FY24 Results Presentation
×
FY24 Results Presentation |
27 August 24 |
Notification regarding unquoted securities - EZZ
×
Notification regarding unquoted securities - EZZ |
27 August 24 |
Change of Director's Interest Notice x3
×
Change of Director's Interest Notice x3 |
15 August 24 |
Notice of FY24 Full Year Results and Investor Webinar
×
Notice of FY24 Full Year Results and Investor Webinar |
06 August 24 |
EZZ Expands Portfolio with 4 Functional Food Products
×
EZZ Expands Portfolio with 4 Functional Food Products |
23 July 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
27 June 24 |
Disclosure of Media Statements
×
Disclosure of Media Statements |
25 June 24 |
EZZ Targets US Expansion Receives Product Approvals from FDA
×
EZZ Targets US Expansion Receives Product Approvals from FDA |
31 May 24 |
EZZ Secures Major Sales Agreement with Pinehills (HK) Ltd
×
EZZ Secures Major Sales Agreement with Pinehills (HK) Ltd |
07 May 24 |
Half Year Interim Dividend
×
Half Year Interim Dividend |
07 May 24 |
Dividend/Distribution - EZZ
×
Dividend/Distribution - EZZ |
24 April 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
15 April 24 |
Application for quotation of securities - EZZ
×
Application for quotation of securities - EZZ |
15 April 24 |
Notice under Section 708A(5)(e) of the Corporations Act 2001
×
Notice under Section 708A(5)(e) of the Corporations Act 2001 |
12 April 24 |
EZZ Completes Private Placement with Strategic Investor
×
EZZ Completes Private Placement with Strategic Investor |
12 April 24 |
Proposed issue of securities - EZZ
×
Proposed issue of securities - EZZ |
27 March 24 |
Investor Presentation 1H FY24 and Market Update
×
Investor Presentation 1H FY24 and Market Update |
29 February 24 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
31 January 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
28 November 23 |
Chair's Address to Shareholders
×
Chair's Address to Shareholders |
28 November 23 |
Results of Meeting
×
Results of Meeting |
27 October 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
27 October 23 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.